{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:10:13Z","timestamp":1785553813440,"version":"3.56.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bpobgyn.2019.01.017","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T08:55:57Z","timestamp":1549788957000},"page":"15-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Foetal and neonatal alloimmune thrombocytopenia"],"prefix":"10.1016","volume":"58","author":[{"given":"Dian","family":"Winkelhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Oepkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2019.01.017_bib1","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/HUMREP\/10.6.1571","article-title":"Cell adhesion molecules on the oocyte and preimplantation human embryo","volume":"10","author":"Campbell","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The human platelet\u00a0alloantigens, PlA1 and PlA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib3","first-page":"697","article-title":"Human platelet antigen frequencies of platelet donors in the French population determined by polymerase chain reaction with sequence-specific primers","volume":"45","author":"Merieux","year":"1997","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(89)91733-9","article-title":"348 cases of suspected neonatal alloimmune thrombocytopenia","volume":"1","author":"Mueller-Eckhardt","year":"1989","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib5","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1537-2995.2004.04026.x","article-title":"Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia","volume":"44","author":"Davoren","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib6","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1016\/j.thromres.2013.05.005","article-title":"Transient macrothrombocytopenia associated with maternal-neonatal HPA-21bw incompatibility","volume":"131","author":"Kunishima","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib7","first-page":"2310","article-title":"Neonatal alloimmune thrombocytopenia","volume":"55","author":"Ohto","year":"1997","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-3148.2004.00535.x","article-title":"The natural history of maternal immunization against foetal platelet\u00a0alloantigens","volume":"14","author":"Ohto","year":"2004","journal-title":"Transfus Med"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1182\/blood.V75.3.684.684","article-title":"Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV","volume":"75","author":"Tomiyama","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1537-2995.1996.36496226147.x","article-title":"Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians","volume":"36","author":"Curtis","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90531-6","article-title":"Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin\/MGDF in megakaryocyte development","volume":"81","author":"Shivdasani","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molimm.2008.10.015","article-title":"HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity","volume":"46","author":"van Gils","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib13","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI77820","article-title":"Maternal anti-platelet beta3 integrins impair angiogenesis and cause intracranial hemorrhage","volume":"125","author":"Yougbare","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib14","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/ATVBAHA.116.307281","article-title":"Antiendothelial alphavbeta3 antibodies are a major cause of intracranial bleeding in fetal\/neonatal alloimmune thrombocytopenia","volume":"36","author":"Santoso","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib15","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1152::AID-PD8>3.0.CO;2-J","article-title":"Severe fetomaternal alloimmune thrombocytopenia presenting with fetal hydrocephalus","volume":"16","author":"Murphy","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0412.2011.01269.x","article-title":"Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys","volume":"91","author":"Tiller","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib17","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ajog.2005.06.043","article-title":"Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy","volume":"193","author":"Althaus","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib18","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199311113292005","article-title":"Fetal thrombocytopenia and its relation to maternal thrombocytopenia","volume":"329","author":"Burrows","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib19","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1182\/blood.V89.12.4402","article-title":"Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group","volume":"89","author":"Dreyfus","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.2013-3320","article-title":"Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review","volume":"133","author":"Kamphuis","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1471-0528.2010.02657.x","article-title":"Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review","volume":"117","author":"Kamphuis","year":"2010","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jcp.55.4.289","article-title":"Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases","volume":"55","author":"Davoren","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2019.01.017_bib23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/trf.13550","article-title":"Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature","volume":"56","author":"Winkelhorst","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002490","article-title":"Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry","volume":"3","author":"Tiller","year":"2013","journal-title":"BMJ open"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib25","first-page":"1","article-title":"Perinatal outcome and long-term neurodevelopment after intracranial haemorrhage due to fetal and neonatal alloimmune thrombocytopenia","author":"Winkelhorst","year":"2018","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1479-828X.2001.tb01293.x","article-title":"Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis","volume":"41","author":"Spencer","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib27","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1537-2995.2008.01748.x","article-title":"External quality assessment of platelet serology and human platelet antigen genotyping: a 10-year review","volume":"48","author":"Porcelijn","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies","volume":"70","author":"Kiefel","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib29","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1471-0528.2011.03039.x","article-title":"Noninvasive fetal genotyping of human platelet antigen-1a","volume":"118","author":"Scheffer","year":"2011","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib30","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/trf.13102","article-title":"Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing","volume":"55","author":"Wienzek-Lischka","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.21307\/immunohematology-2019-401","article-title":"Is there a relationship between anti-HPA-1a concentration and severity of neonatal alloimmune thrombocytopenia?","volume":"21","author":"Bessos","year":"2005","journal-title":"Immunohematology Am Red Cross"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0198-8859(92)90036-M","article-title":"Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201","volume":"34","author":"L'Abbe","year":"1992","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","article-title":"A\u00a0screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia","volume":"110","author":"Kjeldsen-Kragh","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A\u00a0prominent lack of IgG1-Fc fucosylation of platelet\u00a0alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bpobgyn.2019.01.017_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/bjh.14053","article-title":"Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia","volume":"174","author":"Sonneveld","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/trf.13274","article-title":"Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage","volume":"56","author":"Delbos","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1423-0410.2003.00302.x","article-title":"Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?","volume":"84","author":"Radder","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(84)90614-7","article-title":"Prenatal treatment of alloimmune thrombocytopenia","volume":"2","author":"Daffos","year":"1984","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib40","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM198811243192103","article-title":"Antenatal treatment of neonatal alloimmune thrombocytopenia","volume":"319","author":"Bussel","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-3148.1999.00216.x","article-title":"Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia","volume":"9","author":"Sainio","year":"1999","journal-title":"Transfus Med"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2141.2010.08540.x","article-title":"The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources","volume":"152","author":"Knight","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib43","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib44","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/trf.13712","article-title":"Lower-dose intravenous immunoglobulins for the treatment of fetal and neonatal alloimmune thrombocytopenia: a cohort study","volume":"56","author":"Kamphuis","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.AOG.0000270302.80336.dd","article-title":"Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial","volume":"110","author":"Berkowitz","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib46","doi-asserted-by":"crossref","first-page":"135.e1","DOI":"10.1016\/j.ajog.2010.03.011","article-title":"Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus","volume":"203","author":"Bussel","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib47","series-title":"Management of fetal alloimmune thrombocytopenia","first-page":"69","article-title":"On the mechanism of high dose maternal intravenous immunoglobulin (IVIG) in alloimmune thrombocytopenia","author":"Radder","year":"2004"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.earlhumdev.2004.05.007","article-title":"Follow up of children after antenatal treatment for alloimmune thrombocytopenia","volume":"80","author":"Radder","year":"2004","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib49","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2005-06-2562","article-title":"A\u00a0novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy","volume":"107","author":"Ni","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib51","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood-2010-08-302463","article-title":"Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia","volume":"117","author":"Bertrand","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V72.1.340.340","article-title":"Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets","volume":"72","author":"Kaplan","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib53","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9378(96)70582-3","article-title":"Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin","volume":"174","author":"Bussel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib54","first-page":"433","article-title":"Antenatal treatment of fetal alloimmune thrombocytopenia","volume":"80","author":"Wenstrom","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib55","first-page":"67","article-title":"Antenatal treatment of alloimmune thrombocytopenia","volume":"80","author":"Lynch","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib56","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1471-0528.2006.00993.x","article-title":"Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?","volume":"113","author":"van den Akker","year":"2006","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib57","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00431-006-0389-4","article-title":"Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG","volume":"166","author":"te Pas","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2141.2000.02254.x","article-title":"Antenatal screening for fetomaternal alloimmune thrombocytopenia: an evaluation using the criteria of the UK National Screening Committee","volume":"111","author":"Murphy","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib59","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1182\/blood-2005-06-2235","article-title":"Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)","volume":"107","author":"Kiefel","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib60","article-title":"Treatment and outcomes of fetal\/neonatal alloimmune thrombocytopenia: a nationwide cohort study in newly detected cases","author":"Winkelhorst","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib61","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures","volume":"50","author":"Zwiers","year":"2017","journal-title":"Ultrasound Obstet Gynecol\u2013Off J Int Soc Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib64","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1537-2995.2011.03480.x","article-title":"Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model","volume":"52","author":"Tiller","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib65","first-page":"2929","article-title":"Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia","volume":"118","author":"Ghevaert","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2013-02-481887","article-title":"Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers","volume":"122","author":"Ghevaert","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000415163","article-title":"Screening for neonatal alloimmune thrombocytopenia: an economic perspective","author":"Gafni","year":"1988","journal-title":"Curr Stud Hematol Blood Transfus"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOH.0b013e3283317be9","article-title":"Is it time to implement HPA-1 screening in pregnancy?","volume":"16","author":"Husebekk","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib69","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/ehm.10.49","article-title":"Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention","volume":"3","author":"Skogen","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.bpobgyn.2019.01.017_bib70","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1537-2995.2007.01625.x","article-title":"Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in The Netherlands","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693418302189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693418302189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:09:47Z","timestamp":1761498587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693418302189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":70,"alternative-id":["S1521693418302189"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.01.017","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Foetal and neonatal alloimmune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}